<?xml version="1.0" encoding="UTF-8"?>
<urlset xmlns="http://www.sitemaps.org/schemas/sitemap/0.9" xmlns:news="http://www.google.com/schemas/sitemap-news/0.9">
  <url>
    <loc>https://pharmadog.xyz/news/610491</loc>
    <news:news>
      <news:publication>
        <news:name>pharmadog</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-10-29T16:44:05.000Z</news:publication_date>
      <news:title>Federal rule forces PBMs to disclose fees and rebates to employers</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://pharmadog.xyz/news/610492</loc>
    <news:news>
      <news:publication>
        <news:name>pharmadog</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-10-29T16:15:20.000Z</news:publication_date>
      <news:title>STAT Health Tech newsletter previews EPIC probe, Teladoc surprise and AI payment challenges</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://pharmadog.xyz/news/610471</loc>
    <news:news>
      <news:publication>
        <news:name>pharmadog</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-10-29T16:06:04.000Z</news:publication_date>
      <news:title>Eli Lilly lifts guidance by $10 billion as GLP‑1 sales outpace expectations</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://pharmadog.xyz/news/610511</loc>
    <news:news>
      <news:publication>
        <news:name>pharmadog</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-10-29T16:06:00.000Z</news:publication_date>
      <news:title>Genmab shares jump as petosemtamab plus Keytruda halves death risk in head-neck cancer trial</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://pharmadog.xyz/news/610472</loc>
    <news:news>
      <news:publication>
        <news:name>pharmadog</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-10-29T16:05:48.000Z</news:publication_date>
      <news:title>Merck projects continued investment and growth as Keytruda patent expires</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://pharmadog.xyz/news/610303</loc>
    <news:news>
      <news:publication>
        <news:name>pharmadog</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-10-29T15:47:53.000Z</news:publication_date>
      <news:title>BMS shelves Prothena-partnered neuro drug after Phase 1 review, but raises full-year revenue outlook on 7% Q3 sales growth</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://pharmadog.xyz/news/610279</loc>
    <news:news>
      <news:publication>
        <news:name>pharmadog</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-10-29T15:31:16.000Z</news:publication_date>
      <news:title>UK secures £500m biopharma investment as Vertex commits over £300m to new Oxford R&amp;D hub, while Teva plans New Jersey plant closure</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://pharmadog.xyz/news/610280</loc>
    <news:news>
      <news:publication>
        <news:name>pharmadog</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-10-29T15:08:22.000Z</news:publication_date>
      <news:title>Ono Pharma’s endocannabinoid drug ONO-1110 fails five Phase 2 trials, prompting broader concerns</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://pharmadog.xyz/news/610281</loc>
    <news:news>
      <news:publication>
        <news:name>pharmadog</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-10-29T15:06:45.000Z</news:publication_date>
      <news:title>Genmab shares climb after head-and-neck cancer data as Iovance and Coherus stocks fall</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://pharmadog.xyz/news/610111</loc>
    <news:news>
      <news:publication>
        <news:name>pharmadog</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-10-29T14:49:42.000Z</news:publication_date>
      <news:title>Big tech and startups are building personal AI agents to analyze patients’ medical records</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://pharmadog.xyz/news/610155</loc>
    <news:news>
      <news:publication>
        <news:name>pharmadog</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-10-29T14:45:48.000Z</news:publication_date>
      <news:title>RFK Jr. Addresses Iowa Rally Calling for Covid Vaccine Removal and Highlighting MAHA Movement</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://pharmadog.xyz/news/610156</loc>
    <news:news>
      <news:publication>
        <news:name>pharmadog</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-10-29T14:18:27.000Z</news:publication_date>
      <news:title>Michigan Senate candidate El-Sayed rebuts RFK Jr. and highlights FDA&apos;s new enforcement discretion on peptide drugs</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://pharmadog.xyz/news/134233</loc>
    <news:news>
      <news:publication>
        <news:name>pharmadog</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-10-29T13:44:00.000Z</news:publication_date>
      <news:title>CLINUVEL to cut up to 20% of staff and move headquarters to New York</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://pharmadog.xyz/news/609987</loc>
    <news:news>
      <news:publication>
        <news:name>pharmadog</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-10-29T13:43:44.000Z</news:publication_date>
      <news:title>HHS permits compounding of six experimental peptides despite FDA scientists&apos; safety concerns</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://pharmadog.xyz/news/609968</loc>
    <news:news>
      <news:publication>
        <news:name>pharmadog</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-10-29T13:38:58.000Z</news:publication_date>
      <news:title>Ono Pharma halts ONO-1110 development for depression and anxiety after five Phase 2 failures, continues pain studies</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://pharmadog.xyz/news/609988</loc>
    <news:news>
      <news:publication>
        <news:name>pharmadog</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-10-29T13:38:36.000Z</news:publication_date>
      <news:title>Biostatistician Martin Kulldorff Criticizes NIH Gatekeepers Over Measles Claims</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://pharmadog.xyz/news/609879</loc>
    <news:news>
      <news:publication>
        <news:name>pharmadog</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-10-29T13:25:01.000Z</news:publication_date>
      <news:title>Vertex kidney disease drug faces infection risk scrutiny ahead of FDA decision</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://pharmadog.xyz/news/609835</loc>
    <news:news>
      <news:publication>
        <news:name>pharmadog</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-10-29T13:00:32.000Z</news:publication_date>
      <news:title>Anthropic outlines biopharma strategy ahead of potential record-size IPO</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://pharmadog.xyz/news/609859</loc>
    <news:news>
      <news:publication>
        <news:name>pharmadog</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-10-29T12:59:59.000Z</news:publication_date>
      <news:title>Lilly can’t stop, won’t stop as revenue climbs 39% thanks to GLP-1 bestsellers</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://pharmadog.xyz/news/609711</loc>
    <news:news>
      <news:publication>
        <news:name>pharmadog</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-10-29T12:52:11.000Z</news:publication_date>
      <news:title>HHS issues temporary policy permitting compounding pharmacies to produce certain peptide drugs</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://pharmadog.xyz/news/609499</loc>
    <news:news>
      <news:publication>
        <news:name>pharmadog</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-10-29T11:21:53.000Z</news:publication_date>
      <news:title>Eli Lilly beats Q3 revenue forecasts, lifts full-year outlook</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://pharmadog.xyz/news/609523</loc>
    <news:news>
      <news:publication>
        <news:name>pharmadog</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-10-29T11:17:00.000Z</news:publication_date>
      <news:title>HHS adopts enforcement discretion allowing compounding pharmacies to produce six unapproved peptides</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://pharmadog.xyz/news/609500</loc>
    <news:news>
      <news:publication>
        <news:name>pharmadog</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-10-29T11:00:08.000Z</news:publication_date>
      <news:title>Dren Bio secures $350 million to advance blood-cancer therapy toward 2027 launch</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://pharmadog.xyz/news/610254</loc>
    <news:news>
      <news:publication>
        <news:name>pharmadog</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-10-29T10:55:00.000Z</news:publication_date>
      <news:title>Merck says 2027 will focus on pipeline and new product launches despite recent trial wins</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://pharmadog.xyz/news/609331</loc>
    <news:news>
      <news:publication>
        <news:name>pharmadog</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-10-29T10:30:03.000Z</news:publication_date>
      <news:title>Flagship Pioneering merges three portfolio companies to boost AI drug discovery</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://pharmadog.xyz/news/609395</loc>
    <news:news>
      <news:publication>
        <news:name>pharmadog</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-10-29T10:30:00.000Z</news:publication_date>
      <news:title>Flagship Pioneering merges three biotech startups to launch AI-driven drugmaker Etcelera</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://pharmadog.xyz/news/610087</loc>
    <news:news>
      <news:publication>
        <news:name>pharmadog</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-10-29T10:14:00.000Z</news:publication_date>
      <news:title>BioMarin signs up to $475 million licensing deal for new Fabry disease enzyme therapy</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://pharmadog.xyz/news/609207</loc>
    <news:news>
      <news:publication>
        <news:name>pharmadog</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-10-29T10:00:00.000Z</news:publication_date>
      <news:title>New tumor atlas reveals why colorectal cancer is more aggressive in younger patients</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://pharmadog.xyz/news/609187</loc>
    <news:news>
      <news:publication>
        <news:name>pharmadog</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-10-29T09:48:00.000Z</news:publication_date>
      <news:title>Australia emerges as a hub for early-stage clinical trials thanks to speed, clear regulations and tax incentives</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://pharmadog.xyz/news/610086</loc>
    <news:news>
      <news:publication>
        <news:name>pharmadog</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-10-29T09:04:00.000Z</news:publication_date>
      <news:title>BMS drops $80 million neurodegeneration program after phase-1 results</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://pharmadog.xyz/news/609041</loc>
    <news:news>
      <news:publication>
        <news:name>pharmadog</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-10-29T08:30:00.000Z</news:publication_date>
      <news:title>Voters demand action on soaring health-care costs, boosting support for Medicare for All</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://pharmadog.xyz/news/609039</loc>
    <news:news>
      <news:publication>
        <news:name>pharmadog</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-10-29T08:30:00.000Z</news:publication_date>
      <news:title>AI as partner, competitor or crutch? Biologists weigh benefits and risks</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://pharmadog.xyz/news/609040</loc>
    <news:news>
      <news:publication>
        <news:name>pharmadog</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-10-29T08:30:00.000Z</news:publication_date>
      <news:title>Treasury&apos;s Proposed China Investment Rule Sparks Debate Over Licensing Exemptions</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://pharmadog.xyz/news/609042</loc>
    <news:news>
      <news:publication>
        <news:name>pharmadog</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-10-29T08:30:00.000Z</news:publication_date>
      <news:title>Rising employer health premiums pressure workers as industry resists change</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://pharmadog.xyz/news/609138</loc>
    <news:news>
      <news:publication>
        <news:name>pharmadog</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-10-29T05:11:00.000Z</news:publication_date>
      <news:title>Ascletis oral GLP-1 candidate ASC30 meets primary and secondary goals in phase 2 diabetes study</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://pharmadog.xyz/news/608240</loc>
    <news:news>
      <news:publication>
        <news:name>pharmadog</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-10-29T04:01:00.000Z</news:publication_date>
      <news:title>Biopharma manufacturing cuts slated to affect over 4,000 workers, with BioNTech leading layoffs</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://pharmadog.xyz/news/608239</loc>
    <news:news>
      <news:publication>
        <news:name>pharmadog</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-10-29T04:01:00.000Z</news:publication_date>
      <news:title>Biopharma job postings in New York surge 109% year over year, eight firms hiring</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://pharmadog.xyz/news/610382</loc>
    <news:news>
      <news:publication>
        <news:name>pharmadog</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-10-29T04:00:00.000Z</news:publication_date>
      <news:title>Medline orders removal of all brand beds and accessories over fire and asphyxiation hazards</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://pharmadog.xyz/news/606807</loc>
    <news:news>
      <news:publication>
        <news:name>pharmadog</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-10-28T20:51:12.000Z</news:publication_date>
      <news:title>Lawmaker asks GAO to examine TrumpRx claims of $700 million drug savings</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://pharmadog.xyz/news/609810</loc>
    <news:news>
      <news:publication>
        <news:name>pharmadog</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-10-28T20:50:00.000Z</news:publication_date>
      <news:title>Flagship launches Etcelera, an AI-driven biotech combining three platforms to predict drug effects</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://pharmadog.xyz/news/606487</loc>
    <news:news>
      <news:publication>
        <news:name>pharmadog</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-10-28T19:16:37.000Z</news:publication_date>
      <news:title>Zocdoc pushes AI personal agents into healthcare as other sectors restrict their use</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://pharmadog.xyz/news/609642</loc>
    <news:news>
      <news:publication>
        <news:name>pharmadog</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-10-28T18:48:00.000Z</news:publication_date>
      <news:title>Geron halts phase 3 Rytelo trial after data monitoring panel deems unlikely to improve survival in JAK-inhibitor-pretreated myelofibrosis</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://pharmadog.xyz/news/606319</loc>
    <news:news>
      <news:publication>
        <news:name>pharmadog</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-10-28T18:40:59.000Z</news:publication_date>
      <news:title>Formation Bio raises $600 million fund to expand AI-driven drug licensing and testing model</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://pharmadog.xyz/news/606320</loc>
    <news:news>
      <news:publication>
        <news:name>pharmadog</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-10-28T18:21:40.000Z</news:publication_date>
      <news:title>FDA outlines pathway for approval of personalized gene-editing therapies</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://pharmadog.xyz/news/606321</loc>
    <news:news>
      <news:publication>
        <news:name>pharmadog</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-10-28T18:04:01.000Z</news:publication_date>
      <news:title>AstraZeneca’s heart drug Wainua fails late-stage trial, raising 2027 outlook concerns</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://pharmadog.xyz/news/609812</loc>
    <news:news>
      <news:publication>
        <news:name>pharmadog</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-10-28T17:37:00.000Z</news:publication_date>
      <news:title>Oura and UC San Diego Health launch trial linking smart ring data to obesity treatment outcomes</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://pharmadog.xyz/news/606175</loc>
    <news:news>
      <news:publication>
        <news:name>pharmadog</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-10-28T17:07:47.000Z</news:publication_date>
      <news:title>Genmab’s bispecific antibody petosemtamab plus Keytruda cuts death risk by half in Phase 3 head‑and‑neck cancer trial</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://pharmadog.xyz/news/606151</loc>
    <news:news>
      <news:publication>
        <news:name>pharmadog</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-10-28T17:04:59.000Z</news:publication_date>
      <news:title>HHS pauses enforcement of ban on compounding wellness peptides as FDA drafts new rules</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://pharmadog.xyz/news/606027</loc>
    <news:news>
      <news:publication>
        <news:name>pharmadog</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-10-28T16:35:03.000Z</news:publication_date>
      <news:title>HHS adopts temporary policy to let compounding pharmacies produce six unapproved peptides</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://pharmadog.xyz/news/605839</loc>
    <news:news>
      <news:publication>
        <news:name>pharmadog</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-10-28T15:56:00.000Z</news:publication_date>
      <news:title>Biogen sees continued revenue growth and pipeline readouts, M&amp;A not essential, CEO says</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://pharmadog.xyz/news/605815</loc>
    <news:news>
      <news:publication>
        <news:name>pharmadog</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-10-28T15:25:26.000Z</news:publication_date>
      <news:title>Analysts Question Biogen&apos;s Lupus Drug Litifilimab Ahead of Key Phase 3 Readouts</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://pharmadog.xyz/news/605816</loc>
    <news:news>
      <news:publication>
        <news:name>pharmadog</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-10-28T15:15:11.000Z</news:publication_date>
      <news:title>Pfizer shuts India cancer drug plant for up to two years, worsening drug shortages</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://pharmadog.xyz/news/605879</loc>
    <news:news>
      <news:publication>
        <news:name>pharmadog</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-10-28T15:15:00.000Z</news:publication_date>
      <news:title>FDA releases draft guidance to streamline approval of personalized gene therapies</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://pharmadog.xyz/news/605859</loc>
    <news:news>
      <news:publication>
        <news:name>pharmadog</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-10-28T15:14:49.000Z</news:publication_date>
      <news:title>Michigan Senate candidate Abdul El-Sayed vows to challenge RFK Jr. and push Medicare for All</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://pharmadog.xyz/news/605583</loc>
    <news:news>
      <news:publication>
        <news:name>pharmadog</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-10-28T14:52:17.000Z</news:publication_date>
      <news:title>Epic’s dominance forces health-care AI firms to adapt, new STAT+ analysis finds</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://pharmadog.xyz/news/605563</loc>
    <news:news>
      <news:publication>
        <news:name>pharmadog</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-10-28T14:33:06.000Z</news:publication_date>
      <news:title>FDA issues draft guidance to streamline approval of personalized gene therapies and expands CMS access model</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://pharmadog.xyz/news/606462</loc>
    <news:news>
      <news:publication>
        <news:name>pharmadog</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-10-28T14:27:00.000Z</news:publication_date>
      <news:title>FDA proposes new rare disease framework to accelerate therapy development</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://pharmadog.xyz/news/605539</loc>
    <news:news>
      <news:publication>
        <news:name>pharmadog</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-10-28T14:08:53.000Z</news:publication_date>
      <news:title>Chinese biotech BioGeometry secures over $100 million Series A for AI-driven protein design</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://pharmadog.xyz/news/605565</loc>
    <news:news>
      <news:publication>
        <news:name>pharmadog</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-10-28T14:04:04.000Z</news:publication_date>
      <news:title>GSK vaccine sales miss expectations amid falling demand from adults</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://pharmadog.xyz/news/605415</loc>
    <news:news>
      <news:publication>
        <news:name>pharmadog</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-10-28T13:44:59.000Z</news:publication_date>
      <news:title>FDA drafts guidance to speed approvals of individualized gene therapies, hailed as win for rare disease patients</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://pharmadog.xyz/news/605435</loc>
    <news:news>
      <news:publication>
        <news:name>pharmadog</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-10-28T13:27:00.000Z</news:publication_date>
      <news:title>Eli Lilly to merge U.S. and international units after exec retirement; Novartis records $1.9B impairment on failed Avidity drug</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://pharmadog.xyz/news/605371</loc>
    <news:news>
      <news:publication>
        <news:name>pharmadog</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-10-28T13:00:06.000Z</news:publication_date>
      <news:title>Survey finds 78% of scientists expect AI to accelerate drug discovery this year</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://pharmadog.xyz/news/605227</loc>
    <news:news>
      <news:publication>
        <news:name>pharmadog</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-10-28T12:29:20.000Z</news:publication_date>
      <news:title>Astellas signs up to $1.34 billion option deal for Audax&apos;s DAX-044 immuno-oncology candidate</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://pharmadog.xyz/news/605228</loc>
    <news:news>
      <news:publication>
        <news:name>pharmadog</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-10-28T12:12:06.000Z</news:publication_date>
      <news:title>Biogen posts third consecutive quarter of revenue growth, driven by Leqembi, Spinraza and Apellis products</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://pharmadog.xyz/news/605247</loc>
    <news:news>
      <news:publication>
        <news:name>pharmadog</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-10-28T12:01:13.000Z</news:publication_date>
      <news:title>U.S. overdose deaths fell 27% in 2024, with early 2025 data showing further decline</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://pharmadog.xyz/news/606738</loc>
    <news:news>
      <news:publication>
        <news:name>pharmadog</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-10-28T11:58:00.000Z</news:publication_date>
      <news:title>Genmab&apos;s bispecific combo with Keytruda halves death risk in phase 3 head‑neck cancer trial</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://pharmadog.xyz/news/123087</loc>
    <news:news>
      <news:publication>
        <news:name>pharmadog</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-10-28T11:26:00.000Z</news:publication_date>
      <news:title>BioSpace launches dashboard to track performance of U.S. biotech IPOs in 2026</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://pharmadog.xyz/news/604911</loc>
    <news:news>
      <news:publication>
        <news:name>pharmadog</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-10-28T10:45:00.000Z</news:publication_date>
      <news:title>Lilly&apos;s retatrutide outperforms Ozempic in weight loss and blood sugar reduction in head-to-head diabetes trial</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://pharmadog.xyz/news/604868</loc>
    <news:news>
      <news:publication>
        <news:name>pharmadog</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-10-28T10:26:20.000Z</news:publication_date>
      <news:title>Astellas secures exclusive option on Audax Biosciences preclinical IL-12 cancer drug</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://pharmadog.xyz/news/604891</loc>
    <news:news>
      <news:publication>
        <news:name>pharmadog</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-10-28T10:15:39.000Z</news:publication_date>
      <news:title>Merck and Moderna vaccine data leak ahead of ESMO, Merck&apos;s sac-TMT cuts endometrial cancer deaths, BMS reports CAR-T death</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://pharmadog.xyz/news/605682</loc>
    <news:news>
      <news:publication>
        <news:name>pharmadog</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-10-28T10:06:00.000Z</news:publication_date>
      <news:title>Biogen CEO says early-stage R&amp;D now a priority after record five INDs this year</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://pharmadog.xyz/news/604578</loc>
    <news:news>
      <news:publication>
        <news:name>pharmadog</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-10-28T08:30:00.000Z</news:publication_date>
      <news:title>Epic&apos;s data‑blocking tactics curb health‑tech innovation, investigation finds</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://pharmadog.xyz/news/604576</loc>
    <news:news>
      <news:publication>
        <news:name>pharmadog</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-10-28T08:30:00.000Z</news:publication_date>
      <news:title>STAT seeks input on how Epic&apos;s practices affect hospital technology choices</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://pharmadog.xyz/news/604575</loc>
    <news:news>
      <news:publication>
        <news:name>pharmadog</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-10-28T08:30:00.000Z</news:publication_date>
      <news:title>Pediatricians work to calm families and promote MMR vaccination amid Pennsylvania measles outbreak</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://pharmadog.xyz/news/604577</loc>
    <news:news>
      <news:publication>
        <news:name>pharmadog</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-10-28T08:30:00.000Z</news:publication_date>
      <news:title>Physician&apos;s personal egg-freezing story highlights systemic sexism in fertility industry</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://pharmadog.xyz/news/605178</loc>
    <news:news>
      <news:publication>
        <news:name>pharmadog</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-10-28T07:46:00.000Z</news:publication_date>
      <news:title>Lilly&apos;s retatrutide outperforms Ozempic in phase 3 trial, cutting blood sugar and weight more</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://pharmadog.xyz/news/605010</loc>
    <news:news>
      <news:publication>
        <news:name>pharmadog</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-10-28T06:34:00.000Z</news:publication_date>
      <news:title>GSK says UK restructuring will have limited impact on staff, focusing cuts on support roles</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://pharmadog.xyz/news/605012</loc>
    <news:news>
      <news:publication>
        <news:name>pharmadog</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-10-28T05:38:00.000Z</news:publication_date>
      <news:title>Astellas commits up to $285M upfront for Audax&apos;s preclinical IL-12 program, with potential $1.05B milestones</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://pharmadog.xyz/news/603775</loc>
    <news:news>
      <news:publication>
        <news:name>pharmadog</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-10-28T04:24:00.000Z</news:publication_date>
      <news:title>Five newly approved drugs achieve strong launches by offering superior efficacy, pricing and access</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://pharmadog.xyz/news/603776</loc>
    <news:news>
      <news:publication>
        <news:name>pharmadog</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-10-28T04:24:00.000Z</news:publication_date>
      <news:title>Big pharma holds $188 bn for M&amp;A, J&amp;J seen as most likely buyer, analysis shows</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://pharmadog.xyz/news/603777</loc>
    <news:news>
      <news:publication>
        <news:name>pharmadog</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-10-28T04:01:00.000Z</news:publication_date>
      <news:title>Biopharma leader urged to prioritize own job search after team layoffs</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://pharmadog.xyz/news/603778</loc>
    <news:news>
      <news:publication>
        <news:name>pharmadog</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-10-28T04:01:00.000Z</news:publication_date>
      <news:title>Former Novo and Sanofi staff describe mixed layoff experiences, citing severance benefits and poor communication</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://pharmadog.xyz/news/603779</loc>
    <news:news>
      <news:publication>
        <news:name>pharmadog</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-10-28T04:01:00.000Z</news:publication_date>
      <news:title>Biotech firms must adopt global regulatory strategies to commercialize drugs independently</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://pharmadog.xyz/news/607173</loc>
    <news:news>
      <news:publication>
        <news:name>pharmadog</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-10-28T00:00:00.000Z</news:publication_date>
      <news:title>FDA issues draft guidance for electronic IDE submissions via eSTAR</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://pharmadog.xyz/news/602635</loc>
    <news:news>
      <news:publication>
        <news:name>pharmadog</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-10-27T22:31:54.000Z</news:publication_date>
      <news:title>Anthropic acquires one-person biotech Mithril Medicine to expand into life sciences</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://pharmadog.xyz/news/602191</loc>
    <news:news>
      <news:publication>
        <news:name>pharmadog</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-10-27T20:52:03.000Z</news:publication_date>
      <news:title>Mennonite family backs new gene-therapy startup</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://pharmadog.xyz/news/601855</loc>
    <news:news>
      <news:publication>
        <news:name>pharmadog</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-10-27T18:50:49.000Z</news:publication_date>
      <news:title>US Treasury draft COINS rules could sharply limit China biotech partnerships</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://pharmadog.xyz/news/601899</loc>
    <news:news>
      <news:publication>
        <news:name>pharmadog</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-10-27T18:45:34.000Z</news:publication_date>
      <news:title>Missouri AG orders Eli Lilly to stop demanding hospital data for 340B discounts</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://pharmadog.xyz/news/601856</loc>
    <news:news>
      <news:publication>
        <news:name>pharmadog</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-10-27T18:23:59.000Z</news:publication_date>
      <news:title>U.S. judge rejects Novo Nordisk&apos;s bid to block Eli Lilly obesity drug ads</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://pharmadog.xyz/news/601978</loc>
    <news:news>
      <news:publication>
        <news:name>pharmadog</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-10-27T18:18:00.000Z</news:publication_date>
      <news:title>Taylor Farms recalls H-EB Backyard BBQ Chop Salad Kit over possible undeclared soy and almonds</news:title>
    </news:news>
  </url>
</urlset>
